Metabolic

GLP-2 TZ

Dual-Incretin Metabolic Compound - Dual GIP/GLP-1 receptor co-agonist studied in glucose-handling and energy-balance research.

GLP-2 TZ is a dual-incretin research peptide that engages both the GIP and GLP-1 receptors - the two-receptor strategy studied for combined effects on glucose handling, insulin signalling and energy-balance regulation.

Where a single GLP-1 agonist engages one incretin receptor, GLP-2 TZ engages two - the GIP and GLP-1 receptors together. That dual, GIP-forward co-agonism is the property most cited for its amplified effect on glucose handling and body weight in the published literature, and it is the reason the compound is studied as a distinct second-generation incretin tool rather than a single-agonist reference.

GLP-2 TZ specifications

Sequence
GIP / GLP-1 dual receptor agonist peptide
Presentation
Lyophilised powder
Documented purity
99.60% by HPLC
Available sizes
10mg ($85), 30mg ($120), 60mg ($200), 100mg ($260)
Archived COA lots
4
Intended use
Laboratory research use only. Not for human or veterinary use.

Studied pathways

  • Dual incretin signalling - Studied for simultaneous GIP- and GLP-1-receptor activity in glucose-handling and energy-balance models.

Reported mechanisms in the literature

  • Primary incretin axis - Engages the GIP receptor with near-native affinity - the GIP-forward half of the dual-agonist profile studied for insulin signalling and energy handling. (Willard et al.)
  • Co-agonist axis - Simultaneously engages the GLP-1 receptor, combining two incretin signals in one molecule for amplified glucose- and appetite-pathway activity. (Frías et al.)

GLP-2 TZ frequently asked questions

What is GLP-2 TZ?

A dual-incretin research peptide that engages both the GIP and GLP-1 receptors, studied in glucose-handling and energy-balance research models.

Is it approved for human use?

No. It is a laboratory research material only, not a medicine, weight-loss drug, or supplement.

Where is its molecular data?

The molecular weight is printed on the vial label; further structural identifiers are documented on the lot Certificate of Analysis.

Documented to 99.60% purity by HPLC · third-party COA every lot · from $85 · For laboratory research use only.

Related Metabolic compounds

  • GLP-3 RT - Triple-receptor GLP research compound (GLP-1/GIP/glucagon class).
  • 5-Amino-1MQ - Small-molecule NNMT inhibitor studied in metabolism research.
  • MOTS-c - Mitochondrial-derived peptide studied for metabolic regulation.
Browse the catalog View the COA library Verify a lot